FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

426390004: Droxidopa (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661357017 Droxidopa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673595017 L-threo-dihydroxyphenylserine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
2673596016 Droxidopa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673597013 L-threo 3,4 dihydroxyphenylserine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
2661357017 Droxidopa (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2661357017 Droxidopa (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673595017 L-threo-dihydroxyphenylserine en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2673595017 L-threo-dihydroxyphenylserine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673595017 L-threo-dihydroxyphenylserine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
2673596016 Droxidopa en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2673596016 Droxidopa en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673597013 L-threo 3,4 dihydroxyphenylserine en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2673597013 L-threo 3,4 dihydroxyphenylserine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2673597013 L-threo 3,4 dihydroxyphenylserine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
4021000188112 droxidopa fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
4021000188112 droxidopa fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Droxidopa Is a Hydroxyamino acid false Inferred relationship Existential restriction modifier (core metadata concept)
Droxidopa Is a Sympathomimetic agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Droxidopa Is a Amino acid derivative (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Droxidopa Has disposition Alpha-adrenergic and beta-adrenergic agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Droxidopa Is a Substance with alpha-adrenergic and beta-adrenergic agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing droxidopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Droxidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Droxidopa 100mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Droxidopa Inferred relationship Existential restriction modifier (core metadata concept)
Droxidopa 200mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Droxidopa Inferred relationship Existential restriction modifier (core metadata concept)
Droxidopa 300mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Droxidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Droxidopa Inferred relationship Existential restriction modifier (core metadata concept)
Droxidopa 100 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Droxidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Droxidopa Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only droxidopa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Droxidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Droxidopa 100 mg oral capsule Has basis of strength substance (attribute) True Droxidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Droxidopa 100 mg oral capsule Has precise active ingredient True Droxidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Droxidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Droxidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Droxidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Droxidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Droxidopa-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Droxidopa Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only droxidopa in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Droxidopa Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start